LAMEA Interventional Cardiology Devices Market

LAMEA Interventional Cardiology Devices Market Size, Share & Industry Trends Analysis Report By End-use (Hospitals & Clinics, Ambulatory Surgical Centers & Others), By Product, By Country and Growth Forecast, 2023 - 2030

Report Id: KBV-18169 Publication Date: October-2023 Number of Pages: 201
Special Offering:
Industry Insights | Market Trends
Highest number of Tables | 24/7 Analyst Support

Analysis of Market Size & Trends

The Latin America, Middle East and Africa Interventional Cardiology Devices Market would witness market growth of 9.9% CAGR during the forecast period (2023-2030). In the year 2026, the LAMEA market's volume is expected to surge to 6,207.6 thousand units, showcasing a growth of 11.9% (2023-2030).

Interventional surgeries require specialized equipment to repair damaged or compromised blood vessels, constricted arteries, or other affected portions of the heart's structure non-surgically. As a result, cardiac catheterization labs or hospitals use interventional cardiology tools, including cutting balloon catheters, coronary stents, and percutaneous transluminal coronary angioplasty, to undertake minimally invasive procedures. The prevalence of cardiovascular diseases (CVDs), including atrial fibrillation, coronary heart disease, and stroke, is rising. Environmental risk factors, such as pollution, and biological risk factors, such as alcohol consumption, improper diet, tobacco use, and smoking, among others, are to blame for the increase in cardiovascular disease incidence.

In addition, healthcare providers are placing a greater emphasis on shorter hospital stays and fewer postoperative complications. This is causing a rise in minimally invasive interventional cardiovascular interventions. Consequently, these factors have increased the demand for various cardiac procedures. Furthermore, the advantages offered by minimally invasive cardiac procedures, such as smaller incisions, rapid recovery, and lower infection rates compared to other heart surgeries, are responsible for the increasing recommendation of minimally invasive cardiac procedures by healthcare professionals to patients.

The UAE has adopted state-of-the-art imaging technologies for interventional cardiology procedures, including fluoroscopy, angiography, and intravascular ultrasound (IVUS). These technologies provide detailed real-time images of the heart and blood vessels, aiding in precise diagnosis and treatment planning. Three-dimensional (3D) and four-dimensional (4D) imaging techniques have been increasingly used in the UAE for cardiac catheterization and electrophysiology procedures. These technologies offer improved visualization of complex cardiac structures. Continued healthcare infrastructure, research, and technology investment will expand the region’s market.

The Brazil market dominated the LAMEA Interventional Cardiology Devices Market by Country in 2022 and would continue to be a dominant market till 2030; thereby, achieving a market value of $416.2 million by 2030. The Argentina market is showcasing a CAGR of 10.5% during (2023 - 2030). Additionally, The UAE market would register a CAGR of 9.6% during (2023 - 2030).

Based on End-use, the market is segmented into Hospitals & Clinics, Ambulatory Surgical Centers & Others. Based on Product, the market is segmented into Coronary Stents (Drug Eluting Stents, Bare Metal Stents, Bioabsorbable Stents), Accessory Devices (PTCA Guidewires, Diagnostic Catheters, PTCA Guiding Catheters, Introducer Sheaths), PTCA Balloon Catheters (Normal, Specialty, Drug Coated), Intravascular Imaging Catheters & Pressure Guidewires. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.

Free Valuable Insights: The Worldwide Interventional Cardiology Devices Market is Projected to reach USD 21.9 Billion by 2030, at a CAGR of 7.4%

The market research report covers the analysis of key stakeholders of the market. Key companies profiled in the report include Abbott Laboratories, Boston Scientific Corporation, Terumo Corporation, Medtronic PLC, B. Braun Melsungen AG, Biotronik SE & Co. KG, Cardinal Health, Inc., Teleflex, Inc., Koninklijke Philips N.V., Alvimedica.

Scope of the Study

Market Segments Covered in the Report:

By End Use (Volume, Thousand Units, USD Million, 2019-2030)

  • Hospitals & Clinics
  • Ambulatory Surgical Centers & Others

By Product (Volume, Thousand Units, USD Million, 2019-2030)

  • Coronary Stents
    • Drug Eluting Stents
    • Bare Metal Stents
    • Bioabsorbable Stents
  • Accessory Devices
    • PTCA Guidewires
    • Diagnostic Catheters
    • PTCA Guiding Catheters
    • Introducer Sheaths
  • PTCA Balloon Catheters
    • Normal
    • Specialty
    • Drug Coated
  • Intravascular Imaging Catheters & Pressure Guidewires

By Country (Volume, Thousand Units, USD Million, 2019-2030)

  • Brazil
  • Argentina
  • UAE
  • Saudi Arabia
  • South Africa
  • Nigeria
  • Rest of LAMEA

Key Market Players

List of Companies Profiled in the Report:

  • Abbott Laboratories
  • Boston Scientific Corporation
  • Terumo Corporation
  • Medtronic PLC
  • B.Braun Melungeon AG
  • Bortnick SE & Co. KG
  • Cardinal Health, Inc.
  • Teleflex, Inc.
  • Koninklijke Philips N.V.
  • Alvimedica
Need a report that reflects how COVID-19 has impacted this market and its growth? Download Free Sample Now
HAVE A QUESTION?

HAVE A QUESTION?

Call: +1(646) 600-5072

SPECIAL PRICING & DISCOUNTS


  • Buy Sections of This Report
  • Buy Country Level Reports
  • Request for Historical Data
  • Discounts Available for Start-Ups & Universities

Unique Offerings Unique Offerings


  • Exhaustive coverage
  • The highest number of Market tables and figures
  • Subscription-based model available
  • Guaranteed best price
  • Support with 10% customization free after sale

Trusted by over
5000+ clients

Our team of dedicated experts can provide you with attractive expansion opportunities for your business.

Client Logo